We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$26B
AUM Growth
+$2.52B
Cap. Flow
+$734M
Cap. Flow %
2.83%
Top 10 Hldgs %
21.08%
Holding
3,430
New
246
Increased
1,548
Reduced
1,426
Closed
128

Sector Composition

Rank Sector Weight
1 Technology 10.99%
2 Financials 5.01%
3 Consumer Discretionary 4.04%
4 Healthcare 3.7%
5 Industrials 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RKLB icon
3176
Rocket Lab Corp
RKLB
$51.9B
$77K ﹤0.01%
18,694
-1,933
-9% -$8.92K
FUBO icon
3177
FuboTV Inc
FUBO
$293M
$75K ﹤0.01%
3,961
+154
+4% +$4.02K
XERS icon
3178
Xeris Biopharma Holdings
XERS
$1.55B
$75K ﹤0.01%
34,042
+1,872
+6% +$4.84K
MOMO
3179
Hello Group
MOMO
$867M
$74K ﹤0.01%
11,881
-2
-0% -$13
GOEV
3180
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$74K ﹤0.01%
1,032
+593
+135% +$41.3K
NVAX icon
3181
Novavax
NVAX
$1.31B
$73K ﹤0.01%
15,175
-4,057
-21% -$18.8K
GTHX
3182
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$73K ﹤0.01%
16,811
+5,000
+42% +$17.4K
WULF icon
3183
TeraWulf
WULF
$8.58B
$72K ﹤0.01%
27,316
-7,109
-21% -$14K
HNNA icon
3184
Hennessy Advisors
HNNA
$79M
$69K ﹤0.01%
10,062
SABR icon
3185
Sabre
SABR
$831M
$69K ﹤0.01%
28,571
-99,468
-78% -$334K
VRCA icon
3186
Verrica Pharmaceuticals
VRCA
$87.4M
$68K ﹤0.01%
+1,150
New +$63.5K
MFM
3187
Aberdeen Municipal Income Fund
MFM
$223M
$67K ﹤0.01%
12,565
QSI icon
3188
Quantum-Si Incorporated
QSI
$182M
$66K ﹤0.01%
33,355
BBAI icon
3189
BigBear.ai
BBAI
$1.56B
$65K ﹤0.01%
31,500
-3,531
-10% -$7.81K
NRO
3190
Neuberger Real Estate Securities Income Fund Inc
NRO
$188M
$65K ﹤0.01%
20,247
IREN icon
3191
Iris Energy
IREN
$15.6B
$63K ﹤0.01%
+11,600
New +$63K
NRT
3192
North European Oil Royalty Trust
NRT
$83.5M
$63K ﹤0.01%
+10,549
New +$57.5K
MRDN
3193
Meridian Holdings Inc
MRDN
$178M
$62K ﹤0.01%
1,818
AWP
3194
abrdn Global Premier Properties Fund
AWP
$362M
$61K ﹤0.01%
5,174
-3,060
-37% -$34.6K
LWLG icon
3195
Lightwave Logic
LWLG
$1.23B
$61K ﹤0.01%
+12,961
New +$56.4K
SB icon
3196
Safe Bulkers
SB
$760M
$61K ﹤0.01%
+12,311
New +$54.2K
CSBR icon
3197
Champions Oncology
CSBR
$68.8M
$60K ﹤0.01%
+12,252
New +$71.7K
TGB
3198
Trekor Metals
TGB
$3.2B
$60K ﹤0.01%
27,780
ACHR icon
3199
Archer Aviation
ACHR
$4.84B
$59K ﹤0.01%
12,802
-86
-0.7% -$432
CHRS icon
3200
Coherus Oncology
CHRS
$181M
$59K ﹤0.01%
24,643
-180,500
-88% -$444K

Similar funds

Cambridge Investment Research Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Cambridge Investment Research Advisors held 3,430 positions worth $26B, up 11% from $23.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors's Q1 2024 filing shows 246 new, 1,548 increased, 1,426 reduced and 128 closed positions. Its largest new stake was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M. The largest sale was Apple, an estimated $25M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q1 2024 buy was Polen Capital International Growth ETF: 1,886,311 shares worth $18.9M.
  • Cambridge Investment Research Advisors added most to Vanguard Total Bond Market in Q1 2024, an estimated $25.4M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2024 reduction was Apple, cutting an estimated $25M.
  • Cambridge Investment Research Advisors fully exited iMGP RBA Responsible Global Allocation ETF in Q1 2024, selling an estimated $3.97M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $26B portfolio in Q1 2024.
  • Cambridge Investment Research Advisors opened 246 new positions and closed 128 in Q1 2024.
  • Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $26B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.